SPIA
MIRM icon

Steward Partners Investment Advisory’s Mirum Pharmaceuticals MIRM Stock Holding History

Steward Partners Investment Advisory’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
10,714
+5,658
+112% +$568K 0.01% 1154
2026
Q1 		$467K Sell
5,056
-1,175
-19% -$111K ﹤0.01% 1560
2025
Q4 		$492K Buy
6,231
+4,300
+223% +$309K ﹤0.01% 1434
2025
Q3 		$142K Sell
1,931
-1,100
-36% -$69.9K ﹤0.01% 2042
2025
Q2 		$154K Buy
3,031
+981
+48% +$43.7K ﹤0.01% 1881
2025
Q1 		$92.4K Sell
2,050
-750
-27% -$35.4K ﹤0.01% 2058
2024
Q4 		$116K Sell
2,800
-5,864
-68% -$244K ﹤0.01% 1907
2024
Q3 		$338K Sell
8,664
-27,186
-76% -$1.08M ﹤0.01% 1279
2024
Q2 		$1.23M Sell
35,850
-20,850
-37% -$547K 0.01% 744
2024
Q1 		$1.42M Buy
56,700
+17,150
+43% +$471K 0.02% 682
2023
Q4 		$1.17M Buy
39,550
+9,500
+32% +$288K 0.02% 674
2023
Q3 		$950K Buy
30,050
+21,050
+234% +$576K 0.01% 692
2023
Q2 		$233K Sell
9,000
-500
-5% -$13.3K ﹤0.01% 1214
2023
Q1 		$228K Hold
9,500
– – ﹤0.01% 1220
2022
Q4 		$185K Buy
9,500
+2,150
+29% +$42.5K ﹤0.01% 1273
2022
Q3 		$154K Buy
7,350
+6,350
+635% +$153K ﹤0.01% 1310
2022
Q2 		$19K Sell
1,000
-1,000
-50% -$23.6K ﹤0.01% 2248
2022
Q1 		$44K Sell
2,000
-3,000
-60% -$61.2K ﹤0.01% 1977
2021
Q4 		$80K Sell
5,000
-250
-5% -$3.89K ﹤0.01% 1689
2021
Q3 		$105K Buy
5,250
+2,250
+75% +$36.6K ﹤0.01% 1520
2021
Q2 		$52K Buy
+3,000
New +$53.8K ﹤0.01% 3280
2021
Q1 		– Sell
-2,500
Closed -$44K – 3464
2020
Q4 		$44K Buy
+2,500
New +$49.1K ﹤0.01% 1722

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's MIRM Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Mirum Pharmaceuticals (MIRM) stake by 112% in Q2 2026, buying an estimated $568K and bringing the position to 10,714 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #1154.

Steward Partners Investment Advisory first reported a position in MIRM in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.42M in Q1 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Steward Partners Investment Advisory held 10,714 shares of Mirum Pharmaceuticals worth $1.25M as of Q2 2026.
  • Steward Partners Investment Advisory bought 5,658 Mirum Pharmaceuticals shares in Q2 2026, an estimated $568K.
  • Mirum Pharmaceuticals made up 0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1154 holding.
  • Steward Partners Investment Advisory first reported a position in Mirum Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Steward Partners Investment Advisory's Mirum Pharmaceuticals position peaked at $1.42M in Q1 2024.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.